Interaction Checker

Cookies help us deliver our services. By using our services, you agree to our use of cookies. Learn more

New Prescribing Resource – interactions with integrase inhibitors and cations

Thursday 27 February 2020

Integrase inhibitors can bind to polyvalent cations resulting in potentially clinically significant drug interactions with coadministered cation-containing antacids and other supplements/multivitamins. Management of such interactions often requires the temporal separation of the integrase inhibitor from the cation-containing product.

We have produced a new Prescribing Resource which gives a brief description of the nature of these interactions and summarises dosing recommendations (from European and American product labels and this website) when integrase inhibitors are coadministered with cation-containing products.

This document is available as a PDF in the Treatment Selectors (by patient characteristics) subsection of the Prescribing Resources section of the website.

SPONSORS
Sponsor logo janssen Sponsor logo gilead Sponsor logo msd Sponsor logo viiv Logo
EDITORIAL SPONSORS
Hiv  glasgow 2018 cmyk logo Eacs logo 2014 Bhiva 2018 Basel text
Awards and commendations
bma-foundation-for-medical-research british-medical-journal-2018 queens_aniversary_prize_2017 rcp-excellence-patient-care-awards-2017 healthline-best-HIV-and-AIDS-apps-of-2019 building_better_healthcare_awards_2016 healthline-best-HIV-and-AIDS-apps-of-2016